product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
UCHL3 (D25E6) Rabbit mAb
catalog :
8141P
quantity :
40 ul
price :
123 USD
clonality :
monoclonal
host :
rabbit
reactivity :
human, mouse, rat, dog, cow
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/DilutionReference
Carlino M, Fung C, Shahheydari H, Todd J, Boyd S, Irvine M, et al. Preexisting MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients. Clin Cancer Res. 2015;21:98-105 pubmed publisher
Nakakido M, Deng Z, Suzuki T, Dohmae N, Nakamura Y, Hamamoto R. Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN. Neoplasia. 2015;17:367-73 pubmed publisher
Silva A, Wang J, Lomahan S, Tran T, Grenlin L, Suganami A, et al. Aurora kinase A is a possible target of OSU‑03012 to destabilize MYC family proteins. Oncol Rep. 2014;32:901-5 pubmed publisher
Pelosi M, De Rossi M, Barberi L, Musaro A. IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity. Biomed Res Int. 2014;2014:206026 pubmed publisher
product information
SKU :
8141P
Product-Name :
UCHL3 (D25E6) Rabbit mAb
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H, M, R, (B, Dg, Hr)
Applications :
Western blot
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
27
Host :
Rabbit
Target :
UCHL3
Primary-Protein :
UCHL3
Alt-Names :
UCH-L3,UCHL3,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Ubiquitin thioesterase L3,ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase),ubiquitin thiolesterase
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.